These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 304841)

  • 1. Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. III. In vivo protective activity of effector cells generated in vitro.
    Dunlop MB
    Immunology; 1978 Feb; 34(2):291-302. PubMed ID: 304841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective activity of secondary effector T cells generated in vitro against ectromelia virus infection in vivo.
    Kees U; Blanden RV
    Clin Exp Immunol; 1977 Dec; 30(3):338-46. PubMed ID: 203425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T cell response to lymphocytic choriomeningitis virus. Properties of precursors of effector T cells, primary effector T cells and memory T cells in vitro and in vivo.
    Dunlop MB; Doherty PC; Zinkernagel RM; Blanden RV
    Immunology; 1977 Sep; 33(3):361-8. PubMed ID: 302823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. I. Kinetics of induction in vitro and yields of effector cells.
    Dunlop MB; Blanden RV
    Immunology; 1976 Aug; 31(2):171-80. PubMed ID: 955675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell-mediated immune response to ectromelia virus infection. Secondary response in vitro: specificity, nature of effector and responder cells and requirements for induction of antigenic changes in stimulator cells.
    Pang T; Blanden RV
    Aust J Exp Biol Med Sci; 1976 Jun; 54(3):253-64. PubMed ID: 65167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between LCM virus-specific secondary cytotoxic T lymphocytes generated by Con A and by the homologous antigen.
    Marker O; Andersen GT
    Immunology; 1979 Oct; 38(2):235-44. PubMed ID: 315920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary cytotoxic cell response to lymphocytic choriomeningitis virus II. Nature and specificity of effector cells.
    Dunlop MB; Doherty PC; Zinkernagel RM; Blanden RV
    Immunology; 1976 Aug; 31(2):181-6. PubMed ID: 1085282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex.
    Doherty PC; Zinernagel RM
    J Immunol; 1975 Jan; 114(1 Pt 1):30-3. PubMed ID: 1078677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T cell activity is strain-specific in outbred mice infected with lymphocytic choriomeningitis virus.
    Zinkernagel RM; Dunlop MB; Doherty PC
    J Immunol; 1975 Dec; 115(6):1613-6. PubMed ID: 127010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differentiation of cytotoxic T cells in vitro. III. The role of helper T cells and their products in the differentiation of cytotoxic cells from "memory" cell populations.
    Okada M; Henney CS
    J Immunol; 1980 Aug; 125(2):850-7. PubMed ID: 6446579
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological tolerance to lymphocytic choriomeningitis virus in neonatally infected virus carrier mice: evidence supporting a clonal inactivation mechanism.
    Cihak J; Lehmann-Grube F
    Immunology; 1978 Feb; 34(2):265-75. PubMed ID: 304840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis.
    Doherty PC; Zinkernagel RM; Ramshaw IA
    J Immunol; 1974 Apr; 112(4):1548-52. PubMed ID: 4592605
    [No Abstract]   [Full Text] [Related]  

  • 14. MHC and non-MHC genes regulate elimination of lymphocytic choriomeningitis virus and antiviral cytotoxic T lymphocyte and delayed-type hypersensitivity mediating T lymphocyte activity in parallel.
    Thomsen AR; Marker O
    J Immunol; 1989 Feb; 142(4):1333-41. PubMed ID: 2783710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor.
    Zajac AJ; Vance RE; Held W; Sourdive DJ; Altman JD; Raulet DH; Ahmed R
    J Immunol; 1999 Nov; 163(10):5526-34. PubMed ID: 10553080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D.
    Zinkernagel RM; Welsh RM
    J Immunol; 1976 Nov; 117(5 Pt 1):1495-502. PubMed ID: 794412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of anti-Pichinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection or interleukin 2.
    Walker CM; Paetkau V; Rawls WE; Rosenthal KL
    J Immunol; 1985 Aug; 135(2):1401-7. PubMed ID: 2989365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inductive requirements for the generation of virus-specific T lymphocytes. I. The nature of the host cell-virus interaction that triggers secondary poxvirus-specific cytotoxic T lymphocyte induction.
    Hapel AJ; Bablanian R; Cole GA
    J Immunol; 1978 Aug; 121(2):736-43. PubMed ID: 79615
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
    J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
    Kyburz D; Speiser DE; Aebischer T; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5051-8. PubMed ID: 7684417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.